ABBREVIATIONSEID(s)emerging infectious disease(s)PRpathogen reductionBlood as well as blood products are used as part of supporting medical strategies for saving lives. However, qualified donations are not as safe as previously supposed. Except for routinely tested pathogens such as human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis, a large number of infectious agents exist in qualified blood, which can impact blood safety and might turn into transfusion‐transmitted diseases. However, there has been no investigation of the diverse pathogens in pooled plasma from manufacturers to date in China for evaluating the blood safety issue caused by undetected pathogens.Hence, we initiated this study to investigate emerging infectious diseases (EIDs) in pooled plasma from manufacturers in Chengdu and Guiyang, China. Random polymerase chain reaction (PCR) and homology testing were used to determine the microbes in the pooled plasma, and the infection status of EIDs that might jeopardize blood safety was then identified.MATERIALS AND METHODSMaterials collection and treatmentEach 12 mL of pooled plasma (8000 donations) from two manufacturers located in Chengdu, Sichuan Province, and Guiyang, Guizhou Province, China, was collected. The samples were first filtered through a 0.45‐μm‐disk filter and second filtered through a 0.22‐μm‐disk filter (Millex GV). The filtered samples were then ultracentrifuged
Transfusion – Wiley
Published: Jan 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud